33 results about "Vitreoscilla" patented technology

The present invention discloses a high-yield gamma-polyglutamic acid production gene engineering bacterial and a fermentation production method thereof. The gene engineering bacterial is named Bacillus subtilis FRD518, wherein the preservation number is CGMCC NO.6772, and the Vitreoscilla hemoglobin gene (vgb) is recombined and integrated on the chromosome of the gene engineering bacterial, such that the Vitreoscilla hemoglobin VHb can be successfully and highly expressed so as to significantly improve the oxygen utilization rate of the recombinant Bacillus subtilis under a low dissolved oxygen condition. According to the present invention, during a fermentation process, a carbon source, sodium glutamate, a yeast extract and other components are added in a flow manner, such that the gene engineering bacterial can efficiently produce the gamma-polyglutamic acid in a high yield manner, wherein the yield achieves more than 65 g/L, and is increased by 147% compared with the yield of the single batch culture of the original wild strain; and with the gene engineering bacterial, the problems of low yield, more by-products, long period, high energy consumption and the like of fermentation of the gamma-polyglutamic acid gene engineering bacterial under high viscosity and dissolved oxygen limiting conditions are solved, and the gamma-polyglutamic acid gene engineering bacterial can be applied for large-scale industrial production of gamma-polyglutamate acid.

The invention discloses a recombinant plasmid for expressing vitreoscilla hemoglobin in a cell and a construction method of the recombinant plasmid, a genetic engineering bacterium of Gluconobacter oxydans (G.oxydans) and a construction method and application of the genetic engineering bacterium. The recombinant plasmid comprises a vitreoscilla hemoglobin gene vgb, a PtufB promoter of the Gluconobacter oxydans (G.oxydans) and a suitable carrier, wherein the genetic engineering bacterium is obtained by transforming recombinant plasmid into a host bacterium. The genetic engineering bacterium can be used for expressing the vitreoscilla hemoglobin in the cell, can be used for improving the yield of biomass and catalysate 1, 3-dihydroxyacetone under the condition of not changing the existing equipment and energy consumption pressure and provides an effective path for solving the problem of in sufficient oxygen supply in the cell cultivation and catalytic process of the Gluconobacter oxydans (G.oxydans).

An application of vitreoscilla hematoglobin gene in improving the waterlogging resistance of plant is disclosed. Said gene is constructed in the expression vector, which is then transferred to plant cells to make said gene be expressed in plant cells. The resultant transgenic plant has high resistance to waterlogging.

The invention relates, in part, to nucleic acid constructs, genetically modified host cells and methods employing such constructs and host cells to increase the production of 3-methyl-2-butenol from IPP. Thus, in some aspects, the invention provides a genetically modified host cell transformed with a nucleic acid construct encoding a fusion protein comprising a phosphatase capable of catalyzing the dephosphorylation of dimethylallyl diphosphate (DMAPP) linked to an IPP isomerase capable of converting IPP to DMAPP, wherein the nucleic acid construct is operably linked to a promoter. In some embodiments, the genetically modified host cell 5 further comprises a nucleic acid encoding a reductase that is capable of converting 3-methyl-2-butenol to 3-methyl-butanol. In some embodiments, the reductase is encoded by a nucleic acid construct introduced into the cell. In some embodiments, the IPP isomerase is a Type I isomerase. In some embodiments, the IPP isomerase is a Type II isomerase. In some embodiments, the host cell is selected from a group of taxonimcal classes consisting of 20 Escherichia, Enterobacter, Azotobacter, Erwinia, Bacillus, Pseudomonas, Klebsiella, Proteus, Salmonella, Serratia, Shigella, Rhizobia, Vitreoscilla, Synechococcus, Synechocystis, and Paracoccus taxonomical classes. In some embodiments, the host cell is an Escherichia coli cell. In some embodiments, the host cell is a fungal cell, such as a yeast cell. In some embodiments, the yeast cell is a Saccharomyces sp. cell. In some embodiments, the host cell is an algal, insect or mammalian cell line. In some embodiments, the phosphatase is nudB from E. coli. In some embodiments, the IPP isomerase is encoded by an idi gene from E. coli or idil gene from Saccharomyces cerevisiae.

The invention discloses a ganoderic acid high-producing engineering strain kmust-VGB-1, which is preserved in China General Microbiological Culture Collection Center with preservation number of CGMCC NO. 11301. The lucid ganoderma engineering strain kmust-VGB-1 for high production of ganoderic acid is prepared by expressing a vitreoscilla hemoglobin VGB gene through a lucid ganoderma strong promoter P-gpd; through a fermentation experiment in a shaking flask, under the circumstance of avoiding influence on cell growth, yield of monomer ganoderic acids GA-Me, GA-T, GA-Mk and GA-S produced by the VGB converter strain are respectively 3.1 times, 3.2 times, 2.1 times and 3.6 times that of monomer ganoderic acids produced by a WT strain; therefore, the high-producing strain, as an engineering strain for producing the ganoderic acid, has a broad application prospect.

The invention relates to a tylosin gene engineering strain. The construction method for the tylosin gene engineering strain comprises the following steps: cloning tylosin through polymerase chain reaction (PCR) to synthesize crucial rate-limiting enzyme gene TylF and Vitreoscilla hemoglobin VHb gene, constructing a recombinant plasmid by using an E. coli-streptomyces shuttle vector, importing the recombinant plasmid into Escherichia coli ET12567/pUZ8002, performing conjugal transfer culture on the Escherichia coli ET12567/pUZ8002 and streptomyces fradiae spores, converting streptomyces, screening a converter through apramycin resistance, further confirming the converter by using PCR, and finally obtaining the gene engineering strain. The tylosin gene engineering strain can be directly used in the industrial production of tylosin; and compared with the tylosin gene engineering strain used in the conventional industrial production, the tylosin gene engineering strain has the advantages that the yield of the tylosin can be obviously improved to be 17,000-18,000u/ml and the content of a component A in the tylosin is effectively improved to be 94-95 percent.

The invention discloses recombinant corynebacterium glutamicum expressing a vgb gene and an application of the recombinant corynebacterium glutamicum, and belongs to the technical field of genetic engineering. An isoleucine dioxygenase gene ido from bacillus thuringiensis and a hemoglobin gene vgb from vitreoscilla are co-expressed to construct an expression vector pJYW-4-ido-vgb of the recombinant corynebacterium glutamicum; the expression vector is electrically transferred into corynebacterium glutamicum ssp.lactofermentum SN01 for producing L-isoleucine, and the recombinant corynebacterium glutamicum SN01/pJYW-4-ido-vgb is obtained. The recombinant corynebacterium glutamicum can relieve inhibition of a substrate of IDO by L-isoleucine in the production process of 4-HIL (4-hydroxyisoleucine) with L-isoleucine taken as the substrate, so that the fermentation yield of 4-HIL is increased by 50.0%.

The invention discloses a streptomyces diastatochromogenes engineering strain for producing toyocamycin, as well as a construction method and application thereof. Vitreoscilla hemoglobingene (vgb) is integrated on a chromosome of the streptomyces diastatochromogenes engineering strain, so that the toyocamycin expression capability is higher than that of streptomyces diastatochromogenes 1628. The construction process is as follows: 1) constructing an expression vector pIB139-vgb; and 2) utilizing a conjugation method to integrate the expression vector into the chromosome of streptomyces diastatochromogenes to obtain the engineering strain. A promoter permE* on the pIB139 vector is utilized to start the expression of the vgb gene, and the conjugation method is utilized to integrate the specificity of the vector pIB139-vgb into the chromosome of the streptomyces diastatochromogenes 1628 to obtain the engineering strain with stable inheritance. Compared with an original strain, the yield of the recombinant toyocamycin is at least improved by 21.2%, and the concentration of the strain is improved by 11.6%.

The invention discloses a gene-engineered bacterium of gene-recombined peoriae paenibacillus, and a construction method and application of the gene-engineered bacterium. Gene-recombined peoriae paenibacillus BC39 with vitreoscilla hemoglobin regulated and controlled by a P43 strong promoter is constructed by constructing a gene-recombination integrative vector with a peoriae paenibacillus LXH-B-1 strain as host bacteria. The gene-engineered bacterium of the gene-recombined peoriae paenibacillus is capable of intracellularly expressing the vitreoscilla hemoglobin, so that the utilization rate of oxygen by the peoriae paenibacillus, the cell biomass liveweight and the yield of catalysate polypeptide antibiotics can be improved; and the yield of the catalysate polypeptide antibiotics of the engineering strain is increased by 45% compared with that of the original strain; and therefore, an effective way is provided for solving the problem of insufficient oxygen supply in the cell culture and catalysis process of the peoriae paenibacillus.

The invention discloses a genetically engineered bacterium for efficiently synthesizing riboflavin and application of the genetically engineered bacterium, and belongs to the technical field of biological fermentation. The genetically engineered bacterium has the advantages that genes for encoding purR are knocked down, genes for encoding glnR and tnrA are knocked down, hemoglobin from vitreoscilla is overexpressed, dissolved oxygen limitation in the fermentation process is relieved, the energy consumption in the fermentation process is reduced, and the riboflavin yield is increased; and the riboflavin yield of the constructed engineered strain RF1-aPaGaTgV is increased by 50.78% at a shake flask stage, and reaches 2.51 g/L. At the 5-L fermentation level, the highest yield of the riboflavin obtained by adopting the constructed RF1-aPaGaTgV is increased by 45.51% and reaches 10.71 g/L.

The invention relates to a paecilomyces lilacinus strain PNVT8 for expressing the hemoglobin VHb of vitreoscilla and the application of the paecilomyces lilacinus strain PNVT8. The recombinant paecilomyces lilacinus strain PNVT8 is collected in the China center for type culture collection with the collection number of CCTCC No:M 2013296. The paecilomyces lilacinus strain PNVT8 is obtained by optimizing a codon, a promoter and a gene structure, successfully integrating the hemoglobin VHb from the vitreoscilla into a chromosome of a wild paecilomyces lilacinus strain ACSS which has a plant parasitic nematode killing effect and is provided by the agricultural culture collection of China, and performing screening. Compared with the wild paecilomyces lilacinus strain ACSS, the paecilomyces lilacinus strain PNVT8 has the advantages that more extracellular proteases, chitinase, alpha-amylases and the like can be generated, and meanwhile, the biomass and the cell yield are improved; after the paecilomyces lilacinus strain PNVT8 is applied as a product, the growth rate during field planting under a soil micro-aerobic condition also is increased to further improve the nematode larva killing activity.

The invention discloses a recombinant gluconobacter oxydans engineering bacterium and use thereof in a synthesis of a miglitol intermediate. The recombinant gluconobacter oxydans engineering bacteriumis constructed by jointly transferring a vitreoscilla hemoglobin gene vhb and a sorbitol dehydrogenase gene sldAB into a host bacterium. The host bacterium is gluconobacter oxydans. A growth rate ofthe recombinant gluconobacter oxydans and a final activity of a sorbitol dehydrogenase are both improved. Resting cells are used to produce 6-deoxy-6-amino (N-ethoxyl)-alpha-L-furan sorbose. The recombinant gluconobacter oxydans engineering bacterium shows a higher catalytic capacity, can catalytically synthesize 96.1 g/L of 6NSL in a single batch within 24 h, and improves yield of the 6NSL by 9.5% under the same condition compared with G.oxydans/pBBR-sldAB constructed by a patent CN110016455A.

The invention relates to an application of vitreoscilla hemoglobin in improving expression quantity of cephalosporin C acylase, and discloses a method for improving cephalosporin C acylase expressionquantity, which comprises the step of co-expression of a cephalosporin C acylase gene and a vitreoscilla hemoglobin gene in escherichia coli.

The invention relates to the technical field of applied microbiology and genetic engineering, and particularly relates to a recombinant rhamnolipid-producing strain and application thereof in fermentation production of rhamnolipids. According to the method in the invention, a hemoglobin gene vgb from Vitreoscilla stercoralis is connected to an expression vector to construct a recombinant vector PBBR1MCS-5-vgb, the recombinant expression vector is transformed into pseudomonas aeruginosa, the expression of hemoglobin promotes the growth of thalli and the synthesis of rhamnolipids, the ventilatory capacity and fermentation temperature required by fermentation are reduced, and a new technical scheme is provided for effectively reducing the fermentation production cost of rhamnolipids.

kasO*The invention belongs to the field of biotechnology and fermentation engineering, and provides a vitreoscilla hemoglobin expression cassette suitable for streptomyces fradiae and application thereof.The vitreoscilla hemoglobin expression cassette is obtained by connecting a vitreoscilla hemoglobin gene vgbS with a signal peptide SPCynT of carbonic anhydrase CynT in streptomyces fradiae, a streptomyces constitutive strong promoter PkasO * and a streptomyces fradiae terminator Taph; a VHb protein expression cassette PkasO *-SPCynT-vgbS-Taph is formed, and the nucleotide sequence of the expression cassette is as shown in SEQ ID NO. 1. The VHb protein expression cassette PkasO *-SPCynT-vgbS-Taph disclosed by the invention has more efficient VHb expression capacity, and when the VHb protein expression cassette PkasO *-SPCynT-vgbS-Taph is applied to streptomyces fradiae, the VHb expression effect is better, the fermentation product yield of the streptomyces fradiae is higher, and the yield of neomycin is at least increased by 14.9%.